A study recently conducted by the Chinese University of Hong Kong (CUHK) in collaboration with the University of Calgary, Alberta, Canada, revealed a trend of increasing incidence of inflammatory bowel disease (IBD) including ulcerative colitis (UC) and Crohn’s disease (CD) in regions other that the West, with the incidence in Hong Kong increasing more than 30 times over the past 30 years.
A recent study from China showed that faecal microbiota transplantation (FMT) is effective as a therapeutic option for patients with inflammatory bowel disease (IBD).
New endoscopic technologies have improved outcomes for patients with upper gastrointestinal bleeding (UGIB), according to Professor James Lau from the Chinese University of Hong Kong, who reviewed current treatment practices and latest advances at the Asian Pacific Digestive Week (APDW) 2017 held recently in Hong Kong.
Sodium phosphate (NaP) tablets for bowel preparation prior to colonoscopy are safe, better tolerated by patients, and provide equivalent and possibly superior colon cleansing compared with standard polyethylene glycol (PEG) solution, a Korean study has found.
Functional cure of hepatitis B virus (HBV) infection could be possible in the near future with the development of drugs that inhibit HBV replication, recent early-phase clinical studies have shown.
Genotypic resistance-guided therapy is no better than traditional empiric therapy for treating patients with refractory Helibacter pylori infection. Researchers found no significant difference in eradication rate between the two strategies when used in the third-line setting.
Researchers are setting their sights high on immunotherapy as a promising strategy in advanced pancreatic cancer, with several agents currently in development.